205 related articles for article (PubMed ID: 18279620)
1. [Expression and significance of E-cadherin, CD44v6, and proliferating cell nuclear antigen in non-small cell lung cancer].
Weng MX; Wu CH; Yang XP
Ai Zheng; 2008 Feb; 27(2):191-5. PubMed ID: 18279620
[TBL] [Abstract][Full Text] [Related]
2. [Expression of ezrin in human non-small cell lung cancer and its relationship with metastasis and prognosis].
Chen QY; Yan J; Hu HZ; Chen FY; Song J; Jiang ZY; Jiao DM; Wu YQ
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):436-40. PubMed ID: 22967445
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of nucleostemin and proliferating cell nuclear antigen protein expression in non-small cell lung cancer.
Li X; Liu X; Cui D; Wu X; Qian R
J BUON; 2015; 20(4):1088-93. PubMed ID: 26416061
[TBL] [Abstract][Full Text] [Related]
4. Expression of proliferating cell nuclear antigen and CD44 variant isoforms in the primary and metastatic sites of nonsmall cell lung carcinoma with intrapulmonary metastases.
Fukuse T; Hirata T; Naiki H; Hitomi S; Wada H
Cancer; 1999 Oct; 86(7):1174-81. PubMed ID: 10506701
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor.
Hirata T; Fukuse T; Naiki H; Hitomi S; Wada H
Cancer Res; 1998 Mar; 58(6):1108-10. PubMed ID: 9515789
[TBL] [Abstract][Full Text] [Related]
6. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
7. [The expression of vascular endothelial growth factor, CD44v6 in non-small cell lung carcinoma].
Mei TH; Zhang GR; Ma Y
Zhonghua Wai Ke Za Zhi; 2004 Jun; 42(11):647-50. PubMed ID: 15329250
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic significance of E-cadherin and Ki-67 expression in non-small cell lung cancer patients.
He LY; Zhang H; Wang ZK; Zhang HZ
Eur Rev Med Pharmacol Sci; 2016 Sep; 20(18):3812-3817. PubMed ID: 27735037
[TBL] [Abstract][Full Text] [Related]
9. [Expression of standard and variant CD44 in human lung cancer].
Zhao H; Fang J; Du G
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):541-3. PubMed ID: 11360506
[TBL] [Abstract][Full Text] [Related]
10. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis].
Tang XJ; Zhou QH; Zhang SF; Liu LX
Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109
[TBL] [Abstract][Full Text] [Related]
11. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of proliferative activity in pN2 non-small-cell lung carcinomas and their mediastinal lymph node metastases.
Fukuse T; Hirata T; Naiki H; Hitomi S; Wada H
Ann Surg; 2000 Jul; 232(1):112-8. PubMed ID: 10862203
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of expression of proliferating cell nuclear antigen and E-cadherin in gastric carcinoma.
Hu L; Li HL; Li WF; Chen JM; Yang JT; Gu JJ; Xin L
World J Gastroenterol; 2017 May; 23(20):3721-3729. PubMed ID: 28611525
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of high expression of proliferating cell nuclear antigen in non-small cell lung cancer.
Ye X; Ling B; Xu H; Li G; Zhao X; Xu J; Liu J; Liu L
Medicine (Baltimore); 2020 Apr; 99(16):e19755. PubMed ID: 32311975
[TBL] [Abstract][Full Text] [Related]
15. The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer.
Miyoshi T; Kondo K; Hino N; Uyama T; Monden Y
Clin Cancer Res; 1997 Aug; 3(8):1289-97. PubMed ID: 9815811
[TBL] [Abstract][Full Text] [Related]
16. E-cadherin expression in surgically-resected non-small cell lung cancers--a clinicopathological study.
Lee YC; Wu CT; Chen CS; Chang YL
Thorac Cardiovasc Surg; 2000 Oct; 48(5):294-9. PubMed ID: 11100763
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of CD44 variant exon 6 expression in non-small cell lung cancer: a meta-analysis.
Zhao S; He JL; Qiu ZX; Chen NY; Luo Z; Chen BJ; Li WM
Asian Pac J Cancer Prev; 2014; 15(16):6761-6. PubMed ID: 25169522
[TBL] [Abstract][Full Text] [Related]
18. [Relationship of the expression of CD44v6 and paxillin to the prognosis of non-small cell lung carcinoma].
Zuo W; Li H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):484-5. PubMed ID: 12910696
[TBL] [Abstract][Full Text] [Related]
19. [Inverse correlation of S100A4 and E-cad protein expression and their clinical significance in non-small cell lung cancer].
Qi RX; Xu XY
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):681-4. PubMed ID: 18246798
[TBL] [Abstract][Full Text] [Related]
20. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
Nguyen VN; Mirejovský T; Melinová L; Mandys V
Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
